share_log

8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies

8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies

8-K:Kiora Pharmaceuticals公布第二季度业绩;视网膜疾病药物研发渠道正在向两项2期研究迈进
美股SEC公告 ·  2024/08/09 19:07
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息